Virtus ETF Advisers’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-4,539
Closed -$110K 491
2023
Q1
$110K Sell
4,539
-1,748
-28% -$38.3K 0.06% 331
2022
Q4
$135K Sell
6,287
-4,788
-43% -$102K 0.07% 380
2022
Q3
$199K Buy
11,075
+78
+0.7% +$1.02K 0.08% 320
2022
Q2
$106K Buy
10,997
+268
+2% +$3.36K 0.04% 419
2022
Q1
$181K Sell
10,729
-631
-6% -$9.33K 0.08% 205
2021
Q4
$190K Sell
11,360
-22,931
-67% -$376K 0.07% 230
2021
Q3
$557K Sell
34,291
-1,788
-5% -$19.5K 0.25% 122
2021
Q2
$228K Sell
36,079
-7,188
-17% -$46.4K 0.09% 252
2021
Q1
$267K Buy
43,267
+758
+2% +$4.6K 0.11% 271
2020
Q4
$294K Buy
+42,509
New +$272K 0.12% 225
2016
Q4
Sell
-4,702
Closed -$217K 194
2016
Q3
$217K Hold
4,702
0.1% 134
2016
Q2
$240K Buy
4,702
+1,192
+34% +$59.2K 0.18% 104
2016
Q1
$148K Sell
3,510
-225
-6% -$11.5K 0.2% 122
2015
Q4
$293K Buy
+3,735
New +$216K 0.8% 36

Other funds holding ISEE

Virtus ETF Advisers's ISEE Position: Q2 2023 in Review

Virtus ETF Advisers sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q2 2023, closing a stake of 4,539 shares — an estimated $110K sold.

Virtus ETF Advisers first reported a position in ISEE in Q4 2015 and held it in 14 quarters. The position peaked at $557K in Q3 2021. 256 funds tracked by Wall St. Rank hold ISEE as of Q2 2023.

  • Virtus ETF Advisers reported no remaining IVERIC bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Virtus ETF Advisers sold 4,539 IVERIC bio, Inc. Common Stock shares in Q2 2023, an estimated $110K.
  • Virtus ETF Advisers first reported a position in IVERIC bio, Inc. Common Stock in Q4 2015 and held it in 14 quarters.
  • Virtus ETF Advisers's IVERIC bio, Inc. Common Stock position peaked at $557K in Q3 2021.
  • 256 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q2 2023.

Based on Virtus ETF Advisers's 13F filing for Q2 2023, filed 14 Aug 2023.